v3 Template
F

Femasys Inc.

Biomedical / Women's Health Atlanta, USA ~400 employees
Founded
--
Employees (Est.)
~400
20 leaders known
Total Funding
$43.2M
Funding Rounds
6
Last Funding
2025-11-03

About Femasys Inc.

Femasys Inc. is a biomedical company dedicated to addressing unmet needs in women's health worldwide. They focus on providing next-generation advancements and transformative healthcare solutions with a strong emphasis on safety and superior innovation designed for women.

Products & Services

FemaSeed:A product related to infertility treatment.
FemBloc:A solution for birth control.
FemCerv:A product for cancer diagnosis, likely related to cervical cancer.

Specialties

Women's health innovations Infertility solutions Birth control technologies Cancer diagnosis tools

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Senior Secured Convertible Notes
T: -
FT: Senior Secured Convertible Notes
A: 12000000
MR: -
FA: 12 million
FAN: 12000000
D: 2025-11-03
FD: 2025-11-03
1 investors
2 RT: Financing
T: -
FT: Financing
A: 8000000
MR: -
FA: 8 million
FAN: 8000000
D: 2025-09-02
FD: 2025-09-02
1 investors
3 RT: Underwritten Public Offering
T: -
FT: Underwritten Public Offering
A: 8000000
MR: -
FA: $8.0 Million
FAN: 8000000
D: 2025-08-25
FD: 2025-08-25
2 investors
4 RT: Underwritten Public Offering and Concurrent Private Placement
T: -
FT: Underwritten Public Offering and Concurrent Private Placement
A: 4500000
MR: -
FA: $4.5 million
FAN: 4500000
D: 2025-05-30
FD: 2025-05-30
2 investors
5 RT: Senior unsecured convertible note
T: -
FT: Senior unsecured convertible note
A: 6850000
MR: -
FA: 6.85 million
FAN: 6850000
D: 2023-11-15
FD: 2023-11-15
2 investors
6 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 3900000
MR: -
FA: 3.9 million
FAN: 3900000
D: 2023-04-19
FD: 2023-04-19
-
Senior Secured Convertible Notes Latest
2025-11-03
$12.0M
1 investor (Pro only)
Financing 2025-09-02
$8.0M
Underwritten Public Offering 2025-08-25
$8.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

K

Kathy Lee-Sepsick

President and Chief Executive Officer (Founder)

D

Dov Elefant

Chief Financial Officer

J

James H. Liu

Chief Medical Officer

D

Daniel Currie

Chief Operating Officer

C

Christine Thomas

Chief Regulatory & Clinical Officer

M

Mary An Merchant

Vice President Counsel, Intellectual Property

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

Femasys Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biomedical / Women's Health
Company Size
~400 employees (est.)
Locations
Atlanta, USA
Atlanta

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro